Bevel, N., Thorpe, M., & Vanniasinkam, T. (2024). Is drug interference still an issue for pretransfusion testing of patients on anti CD38 and other monoclonal antibody therapies? Vox Sanguinis, 119(8), 785. https://doi.org/10.1111/vox.13649
Chicago Style (17th ed.) CitationBevel, Nichole, Meagan Thorpe, and Thiru Vanniasinkam. "Is Drug Interference Still an Issue for Pretransfusion Testing of Patients on Anti CD38 and Other Monoclonal Antibody Therapies?" Vox Sanguinis 119, no. 8 (2024): 785. https://doi.org/10.1111/vox.13649.
MLA (9th ed.) CitationBevel, Nichole, et al. "Is Drug Interference Still an Issue for Pretransfusion Testing of Patients on Anti CD38 and Other Monoclonal Antibody Therapies?" Vox Sanguinis, vol. 119, no. 8, 2024, p. 785, https://doi.org/10.1111/vox.13649.